Clinic for Diagnostic and Interventional Neuroradiology, Saarland University Hospital, Homburg/Saar, Germany.
AJNR Am J Neuroradiol. 2012 Aug;33(7):1317-20. doi: 10.3174/ajnr.A2962. Epub 2012 Feb 2.
Several studies have shown promising results for the use of self-expandable intracranial stents for the treatment of acute ischemic stroke. This new technique combines immediate flow restoration after stent deployment with high recanalization rates. In the present study, the safety and efficacy of the new Aperio clot-removal device was tested in comparison with the Solitaire AB device.
The experiments were performed in swine with a weight of 35-50 kg following established models. The experimental thrombi were prepared by using a new flow model (Thrombus Loop) to produce radiopaque thrombi. Thrombi were cut into lengths of 10 mm and injected into the target vessel. The occlusion was verified by DSA and rated with the help of the TICI score. A microcatheter was placed distal to the thrombus. The devices were placed with the proximal third within the thrombus and were retrieved under continuous aspiration in their released state into the guiding sheath. We performed 23 procedures with the Aperio device and 18 procedures with the Solitaire AB and FR devices. Control angiograms were obtained 3 and 5 minutes after device deployment to evaluate the flow restoration. The number of attempts to reach a TICI 2/3 score was recorded as well as the time to recanalization and the device-related complications. Vasospasm, vascular perforation, intramural arterial dissection, or embolization of a previously uninvolved territory was defined as a device-related complication.
Defined radiopaque thrombi from whole blood could reliably be created by using the Thrombus Loop. Both devices demonstrated a high recanalization rate of 100% (TICI 3) in the target vessel with no device-related complications. No significant differences were found between the 2 devices.
In this small study, we could show that radiopaque thrombi of whole blood with a defined diameter could be reliably created by using the Thrombus Loop. The new "stent-retriever" (Aperio System) seems to be a very efficient and safe addition to the existing repertoire of clot-removal devices.
多项研究表明,使用自膨式颅内支架治疗急性缺血性卒中具有良好的效果。该新技术结合了支架扩张后即刻恢复血流和高再通率。本研究旨在比较新型 Aperio 血栓抽吸装置与 Solitaire AB 装置的安全性和有效性。
实验在体重 35-50kg 的猪中进行,采用既定模型。通过一种新的血流模型(血栓环)制备放射性不透射线血栓,将其切成 10mm 长并注入靶血管。通过 DSA 验证闭塞并使用 TICI 评分进行评分。在血栓远端放置微导管。将装置放置在血栓近端的前三分之一处,并在释放状态下通过连续抽吸将其拉入引导鞘内。我们使用 Aperio 装置进行了 23 次操作,使用 Solitaire AB 和 FR 装置进行了 18 次操作。在装置放置后 3 分钟和 5 分钟时进行对照血管造影,以评估血流恢复情况。记录达到 TICI 2/3 评分的尝试次数、再通时间和与装置相关的并发症。血管痉挛、血管穿孔、血管壁内夹层或先前未受累区域的栓塞被定义为与装置相关的并发症。
使用血栓环可以可靠地创建来自全血的定义明确的放射性不透射线血栓。两种装置在靶血管中的再通率均为 100%(TICI 3),且无与装置相关的并发症。两种装置之间无显著差异。
在这项小型研究中,我们能够证明使用血栓环可以可靠地创建具有定义直径的全血放射性不透射线血栓。新型“支架回收器”(Aperio 系统)似乎是一种非常有效和安全的血栓清除装置。